Close Menu

This article has been updated to clarify FDA's regulatory exemption plans for firms marketing similar tests. 

NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted premarket authorization for 10 genetic health risk reports from consumer-focused testing company 23andMe.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.